153 related articles for article (PubMed ID: 36810911)
1. TGFβ carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinoma.
Ludwig N; Yerneni SS; Harasymczuk M; Szczepański MJ; Głuszko A; Kukwa W; Jordan T; Spanier G; Taxis J; Spoerl S; Meier JK; Hinck CS; Campbell PG; Reichert TE; Hinck AP; Whiteside TL
Br J Cancer; 2023 May; 128(9):1733-1741. PubMed ID: 36810911
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of PD-L1
Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
[TBL] [Abstract][Full Text] [Related]
3. TGFβ
Ludwig N; Yerneni SS; Azambuja JH; Pietrowska M; Widłak P; Hinck CS; Głuszko A; Szczepański MJ; Kärmer T; Kallinger I; Schulz D; Bauer RJ; Spanier G; Spoerl S; Meier JK; Ettl T; Razzo BM; Reichert TE; Hinck AP; Whiteside TL
J Extracell Vesicles; 2022 Dec; 11(12):e12294. PubMed ID: 36537293
[TBL] [Abstract][Full Text] [Related]
4. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
5. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
[TBL] [Abstract][Full Text] [Related]
6. Separation of plasma-derived exosomes into CD3
Theodoraki MN; Hoffmann TK; Whiteside TL
Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling.
Du L; Chen X; Cao Y; Lu L; Zhang F; Bornstein S; Li Y; Owens P; Malkoski S; Said S; Jin F; Kulesz-Martin M; Gross N; Wang XJ; Lu SL
Oncogene; 2016 Sep; 35(35):4641-52. PubMed ID: 26876212
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Horikawa M; Ida S; Tada H; Matsuyama T; Misawa K; Takeda S; Chikamatsu K
Oral Oncol; 2023 Jan; 136():106270. PubMed ID: 36462328
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells.
Ludwig N; Yerneni SS; Razzo BM; Whiteside TL
Mol Cancer Res; 2018 Nov; 16(11):1798-1808. PubMed ID: 30042174
[TBL] [Abstract][Full Text] [Related]
10. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).
Li X; Zhang Q; Zhang M; Luo Y; Fu Y
Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
[No Abstract] [Full Text] [Related]
15. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
[TBL] [Abstract][Full Text] [Related]
17. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
18. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
19. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.
Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH
Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144
[TBL] [Abstract][Full Text] [Related]
20. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
